Increased Distributions Declared by Destra Multi-Alternative Fund

The Destra Multi-Alternative Fund (the “Fund” or “DMA”), a closed-end fund traded on the New York Stock Exchange under the symbol DMA, is pleased to announce that its Board of Trustees have approved distributions for December 2025 through September 2026. The rate has been declared at $0.1125 per share in each month.

“We are pleased with the continued portfolio transformation and the performance that Validex has delivered to support the monthly distributions,” said, Robert A. Watson, CFP®, President of the Fund. The distribution rate of $0.1125 per share, which the Board has approved for the next ten months, represents a $0.02 per share or 21.6% increase over the previous October and November 2025 distributions of $0.0925 per share. The new distribution reflects a ~13.21% annualized rate at the NAV as of December 5, 2025 of $10.22 per share and corresponds to a ~15.46% annualized rate at the closing MKT price on the same date of $8.73”.

“We continue to transition more of the portfolio into liquid hedged strategies, utilizing our Validex Dynamic Alpha process and it has generated encouraging results,” said Mark Scalzo, Portfolio Manager and CIO of Validex Global Investing, the Fund’s Sub-Adviser.

The Fund offers a Dividend Reinvestment Plan (“DRP”). Shareholders who hold their shares at a broker dealer and would like to participate in the DRP should contact their broker dealer to set their reinvestment preferences. Shareholders who hold their shares directly with the Fund will have all dividends declared on the shares automatically reinvested in additional shares by the Fund’s plan agent, Equiniti Trust Company, LLC (“EQ”), unless the shareholder elects otherwise by contacting EQ. Shareholders who elect not to participate in the DRP will receive all dividends and other distributions in cash, paid by check and mailed directly to the shareholder of record. Shareholders may obtain more information on the shareholder services offered to the Fund by calling EQ at the Fund’s dedicated toll free number 800-591-8238.

A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain, or return of capital. As required by Section 19(a) of the Investment Company Act of 1940 and Rule 19a-1 thereunder, a notice will be distributed to shareholders in the event that a portion of a monthly distribution is derived from sources other than undistributed net investment income. The final determination of the source and tax characteristics of these distributions will depend upon the Fund’s investment experience during its fiscal year and will be made after the Fund’s fiscal year end. The Fund will send shareholders a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes, but shareholders should consult their own tax advisers regarding their specific tax situations and to obtain a complete understanding of the tax consequences. For further information regarding the Fund’s distributions, please visit www.destracapital.com.

About Destra Multi-Alternative Fund

Destra Multi-Alternative Fund (NYSE: DMA) is a core alternative solution that seeks to achieve long-term performance non-correlated to the broad stock and bond markets. It invests primarily in alternative strategies and asset classes centered on the Validex Dynamic Alpha hedged equity process, which is further diversified by allocations to direct private equity and alternative income sub-categories like real estate & alternative credit.

About Destra Capital Advisors

Destra Capital Advisors LLC, based in Bozeman, MT, serves as Investment Adviser and Secondary Market Servicing agent to the Fund. Validus Growth Investors LLC (dba Validex Global Investing) serves as the Investment Sub-Adviser to the Fund.

Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.

Information regarding the Fund and Destra Capital Advisors can be found at www.destracapital.com

About Validex Global Investing

Validex Global Investing seeks growth at the edge of inflection. Their proprietary research aims to identify emergent turning points as they unfold, pairing high-conviction opportunities with sophisticated risk-mitigation strategies across both private and public markets.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251209776363/en/